Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV
-
PRESS RELEASE: CMB.TECH announces special general meeting on 8 October 2026
-
Intel Foundry and ASML Collaborate to Accelerate Industry Readiness for High NA EUV
-
Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 08
-
Guardian Metal Resources PLC Announces Admission to FTSE AIM 50 Index
-
AGCO Power: Forestry Machines Need Purpose-Built Off-Road Engines – Not Compromises
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
-
Reinvention Expert Aidan McCullen Will Be Keynote Speaker at QAD | Redzone Champions of Manufacturing 2026
-
Pragmatic Semiconductor Appoints Dr. Paul James as Executive Vice President Manufacturing & Operations
-
Main Capital Partners enters the UK market with acquisition of Orgvue
-
Autoliv Advances Vehicle Safety Through Virtual Testing
-
Lerøy Seafood Group ASA – Green bond mandate announcement
-
Agreement signed on the sale of shares in UAB Litagra
-
Rapid Nutrition Reports 227.5% H1 Revenue Growth as Group Enters Transformational Second Half
-
Aktsiaselts Infortar subsidiary OÜ Infortar Agro to acquire a 100% shareholding in Lithuanian agricultural company Litagra
-
NBPE Announces Transaction in Own Shares
-
Pragmatic Semiconductor Appoints Dr. Paul James as Executive Vice President Manufacturing & Operations
-
Progress on share buyback programme
-
Equinor ASA: Share buy-back – third tranche for 2026
-
Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial
-
Gaming Realms PLC Announces Interim Results
-
Flysound Brings B02 Open-Fit AI Hearing Aid to the U.S.
-
Skanska to rehabilitate I-395 Northbound Bridge over the Potomac River, USA, for USD 113M, about SEK 1.1 billion
-
Latest Crypto News: Apeing’s Crypto Presale Set to Go Live in Less Than 24 Hours as Ethereum Tests $2,520
-
GCCL Strengthens Asia-Pacific Presence at Asia Bio Partnering Forum 2026
-
The 24th China International Equipment Manufacturing Exposition Kicks off in Shenyang
-
AB “Novaturas” has entered into agreements to transfer its own shares, exercising the options granted to employees in 2022 and 2023
-
The Jollibee Group Reports Record Q2 2026 Results, with Margin Recovery from Controlled Pricing and Record-High Quarterly Net Income Attributable to Equity Holders of the Parent Company
-
GenSight Biologics Provides September 2026 Business Updates
-
MEMSCAP Announces the Cancellation of 105,483 Shares, Representing 1.37% of Its Share Capital, Acquired Under Its Share Buyback Program of December 2, 2024
-
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
-
SEMIFIVE Commences Mass Production of HyperAccel's LLM AI Inference Accelerator 'Bertha' on Samsung 4nm, Spurring Growth Momentum
-
JCB Partners with Sleeping Giant Media to Strengthen Digital Authority across Europe
-
Sigma Announces 85mm F1.2 DG | Art, Unparalleled Rendering with Unprecedented Mobility
-
Sigma Announces 20-60mm F2.8-4 DG | Contemporary, a Standard Zoom Starting at Ultra-Wide
-
Fujifilm Launches ETERNA ProRemote, Remote Control App for FUJIFILM GFX ETERNA 55 Filmmaking Camera
-
Fujifilm Launches VF-GFXC2, Dedicated Electronic Viewfinder for FUJIFILM GFX ETERNA 55 Filmmaking Camera
-
PLATINUM EQUITY TO SELL DE WAVE GROUP FOLLOWING MULTI-YEAR TRANSFORMATION
-
PT Prodia Diacro Laboratories Receives Frost & Sullivan's 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellenc
-
Sigma Announces New 85mm F1.2 Art, 20-60mm F 2.8-4 Contemporary Lenses; YouTube First Look Video and More Info at B&H
-
Sigma Announces New 85mm F1.2 Art, 20-60mm F 2.8-4 Contemporary Lenses; YouTube First Look Video and More Info at B&H
-
Start of Day Message
-
Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)
-
RUBIS: H1 2026 Results - Strong performance leading way to upgrade of 2026 guidance
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Ascom secures major framework agreement and two subsequent project awards, strengthening its long-term presence in Norway’s healthcare market
-
Goldgroup Reports Strong First Results from 26,000 Metre San Francisco Drill Program
-
12 Years of Luvme Hair: What Good Hair Quality Means Beyond First Impressions
-
CNCF and SlashData Report Highlights China's Cloud Native Momentum as AI Moves to Inference
